These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 1671098)

  • 21. Pentaerithrityl tetranitrate and its phase I metabolites are potent activators of cellular cyclic GMP accumulation.
    Hinz B; Kuntze U; Schröder H
    Biochem Biophys Res Commun; 1998 Dec; 253(3):658-61. PubMed ID: 9918783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
    Martin W; White DG; Henderson AH
    Br J Pharmacol; 1988 Jan; 93(1):229-39. PubMed ID: 2894877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide.
    Patel MJ; Wypij DM; Rose DA; Rimele TJ; Wiseman JS
    J Pharmacol Exp Ther; 1995 Apr; 273(1):16-25. PubMed ID: 7536242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA; García A
    J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
    Rodriguez-Pascual F; Miras-Portugal MT; Torres M
    Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
    Brunner F; Schmidt K; Nielsen EB; Mayer B
    J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P-450 mediates bioactivation of organic nitrates.
    Schröder H
    J Pharmacol Exp Ther; 1992 Jul; 262(1):298-302. PubMed ID: 1352550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase.
    Zellers TM; Wu YQ; McCormick J; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Feb; 21(2):131-8. PubMed ID: 11263259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
    Ijioma SC; Challiss RA; Boyle JP
    Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The L-arginine-NO pathway and cyclic GMP in the vessel wall.
    Stoclet JC
    Z Kardiol; 1991; 80 Suppl 7():87-90. PubMed ID: 1665267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.
    Leitman DC; Agnost VL; Tuan JJ; Andresen JW; Murad F
    Biochem J; 1987 May; 244(1):69-74. PubMed ID: 2889449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase activation.
    Johns RA; Tichotsky A; Muro M; Spaeth JP; Le Cras TD; Rengasamy A
    Anesthesiology; 1995 Oct; 83(4):823-34. PubMed ID: 7574063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.
    Pou S; Pou WS; Rosen GM; el-Fakahany EE
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):547-52. PubMed ID: 1671745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.
    Katsuki S; Arnold W; Mittal C; Murad F
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
    Ishii K; Chang B; Kerwin JF; Huang ZJ; Murad F
    Eur J Pharmacol; 1990 Feb; 176(2):219-23. PubMed ID: 2155799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
    Hinz B; Schröder H
    Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
    Johns RA; Peach MJ; Linden J; Tichotsky A
    Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
    Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
    Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.